Westlake

WLK · NYSE

$62.69+$0.40 (+0.64%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $62.29

WLK analyst rating

HoldConsensus of 16 analysts over the last 12 months. 31% rate it a buy.

Strong buy0
Buy5
Hold10
Underperform1
Sell0

12-month price target · 19 analysts

Average $87.36 (+39.3% upside)

Low: $67.67
Now: $62.69
High: $122.09

Upgrades and downgrades

The latest rating actions, newest first

WLK analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
JP Morgan	Oct 16, 2026	Maintains	Neutral	$80.00 → $65.00	57%
Barclays	Oct 13, 2026	Initiates	Underweight	$66.00	50%
RBC Capital	Oct 13, 2026	Maintains	Outperform	$95.00 → $74.00	46%
UBS	Oct 5, 2026	Maintains	Buy	$98.00 → $86.00	49%
Truist Securities	Oct 1, 2026	Maintains	Buy	$104.00 → $90.00	43%
Wells Fargo	Oct 1, 2026	Maintains	Equal-Weight	$89.00 → $68.00	33%
Citigroup	Sep 30, 2026	Maintains	Neutral	$85.00 → $67.00	53%
UBS	Sep 25, 2026	Maintains	Buy	$106.00 → $98.00	49%
Keybanc	Sep 11, 2026	Initiates	Overweight	$92.00	30%
BMO Capital	Sep 9, 2026	Downgrade	Outperform → Market Perform	$96.00 → $82.00	50%

The case for and against

Updated Oct 17, 2026

Bull case

Westlake is positioned to benefit from a vertically integrated model that combines commodity chemicals with higher-margin building products, which the market has not fully reflected in its valuation. Its HIP segment adds stability, supports margin expansion through pricing actions and cross-selling, and offers a long runway for accretive bolt-on M&A backed by balance sheet capacity, while the company’s ~$600M EBITDA improvement plan and Q2/FY26/FY27 EBITDA of $630M/$1.96B/$2.185B signal meaningful earnings upside. Despite near-term cost and demand headwinds in chemicals, solid order books, rising operating rates, low customer inventories, and strong infrastructure-linked demand in pipes, fittings, and siding/trim support a constructive fundamental outlook.

Bear case

Westlake is facing a weaker fundamental setup as 2026E/27E EBITDA estimates were cut to $1.71B/$1.864B from $1.935B/$2.061B, reflecting softer performance in both chemicals and HIP. Management’s Cologne PVC plant closure, planned for 1Q27, underscores high-cost European exposure and will carry about $205M of pre-tax charges, while weak regional demand, elevated energy and logistics costs, and Asian export competition keep operating conditions under pressure. At the same time, 3Q earnings are expected to decline q/q as polyethylene and PVC prices normalize, and HIP margins remain squeezed by diesel-driven freight inflation and residential housing weakness amid higher interest rates.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.